Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Raguu17on Feb 16, 2018 1:26pm
152 Views
Post# 27573564

RE:RE:On going good news

RE:RE:On going good news Thanks, I had not seen this.&nbsp;<br /> <br /> Canaccord is the main financier of ACB. They have 100m that get released via a debenture deal (@$6.50/shr) on March 10th. With every other one of these the bashers have come out at claimed that was the day we started to go to the $6.50 &quot;target&quot;. Not so, those shares are either already shorted and covered by Canaccord OR they are being sold right now. Either way they use the cheap debentures to &quot;backstop&quot; their shorts. The next deal they did was 200m @ $13/shr. Those are released on May 9th. I expect Canaccord to continue to MANIPULATED as per all the others. They have sold their debenture shares at roughly 2-2.5x. Go follow out the forced conversions and the spike that occurs surrounding these dates.&nbsp;<br /> <br /> The next &quot;forced conversion&quot; is &quot;targetted&quot; at $17. Read into that what you will.&nbsp;<br /> <br />
Bullboard Posts